Lidex-E (Fluocinonide Topical) - Summary

LIDEX-E SUMMARY

LIDEX-E^®
(fluocinonide)
Cream 0.05%

LIDEX-E^® (fluocinonide) Cream 0.05% is intended for topical administration. The active component is the corticosteroid fluocinonide, which is the 21-acetate ester of fluocinolone acetonide and has the chemical name pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-6,9-difluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)],(6α,11β,16α)-.

LIDEX-E Cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

See all Lidex-E indications & dosage >>

LIDEX-E NEWS HIGHLIGHTS

Published Studies Related to Lidex-E (Fluocinonide Topical)

Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. [1999.01]

Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis. [1998.05]

Comparative study of calcipotriene (MC 903) ointment and fluocinonide ointment in the treatment of psoriasis. [1994.11]

Double-blind clinical trial of 0.05% clobetasol propionate (corrected from proprionate) ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases. [1994.06]

Fluocinonide in an adhesive base for treatment of oral lichen planus. A double-blind, placebo-controlled clinical study. [1993.02]

more >>

Clinical Trials Related to Lidex-E (Fluocinonide Topical)

Sorafenib-Induced Rash Treatment [Recruiting]

more >>